Provider: NIHR Journals Library
Content:text/plain; charset="UTF-8"
TY  - BOOK
LB  - 1.
AU  - Ferlay, J
AU  - Bray, F
AU  - Pisani, P
AU  - Parkin, DM
TI  - GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide
IS  - Version 1.0. IARC CancerBase No. 5
CY  - Lyon
PB  - International Agency for Research on Cancer Press
PY  - 2001
ER  - 
TY  - ELEC
LB  - 2.
AU  - Office for National Statistics
TI  - MB1 No. 37: Registrations of cancer diagnosed in 2006, England
PY  - 2008
UR  - http://www.statistics.gov.uk/StatBase/Product.asp?vlnk=8843
ER  - 
TY  - ELEC
LB  - 3.
AU  - Welsh Cancer Intelligence and Surveillance Unit
TI  - Cancer incidence in Wales 2003–2007
PY  - 2009
UR  - www.wcisu.wales.nhs.uk
ER  - 
TY  - JOUR
LB  - 4.
AU  - Willett, W
TI  - The search for the causes of breast and colon cancer
J2  - Nature
PY  - 1999
VL  - 338
SP  - 389
EP  - 394
ER  - 
TY  - JOUR
LB  - 5.
AU  - Reddy, B
AU  - Engle, A
AU  - Katsifis, S
AU  - Simi, B
AU  - Bartram, HP
AU  - Perrino, P
TI  - Biochemical epidemiology of colon cancer: effect of types of dietary fiber on fecal mutagens, acid, and neutral sterols in healthy subjects
J2  - Cancer Res
PY  - 1989
VL  - 49
SP  - 4629
EP  - 4635
ER  - 
TY  - JOUR
LB  - 6.
AU  - Potter, JD
TI  - Reconciling the epidemiology, physiology, and molecular biology of colon cancer
J2  - J Am Med Assoc
PY  - 1992
VL  - 268
SP  - 1573
EP  - 1577
ER  - 
TY  - JOUR
LB  - 7.
AU  - Centre for Reviews and Dissemination (CRD) UoY
TI  - The management of colorectal cancers
J2  - Effective Health Care
PY  - 2004
VL  - 8
SP  - 1
EP  - 12
ER  - 
TY  - GEN
LB  - 8.
AU  - National Institute for Health and Clinical Excellence (NICE)
TI  - Guidance on cancer services: improving outcomes in colorectal cancers (manual update)
CY  - London
PB  - NICE
PY  - 2004
ER  - 
TY  - JOUR
LB  - 9.
AU  - Mason, P
TI  - Colorectal cancer – the disease and its management
J2  - Hosp Pharm
PY  - 2004
VL  - 11
SP  - 175
EP  - 177
ER  - 
TY  - JOUR
LB  - 10.
AU  - Hill, MJ
AU  - Morson, BC
AU  - Bussey, HJ
TI  - Aetiology of adenoma–carcinoma sequence in large bowel
J2  - Lancet
PY  - 1992
VL  - i
IS  - 8058
SP  - 245
EP  - 247
ER  - 
TY  - JOUR
LB  - 11.
AU  - Ramsoekh, D
AU  - van Leerdam, ME
AU  - Wagner, A
AU  - Kuipers, EJ
TI  - Review article: detection and management of hereditary non-polyposis colorectal cancer (Lynch syndrome)
J2  - Aliment Pharmacol Ther
PY  - 2007
VL  - 26
IS  - Suppl. 2
SP  - 101
EP  - 111
ER  - 
TY  - JOUR
LB  - 12.
AU  - Eaden, JA
AU  - Abrams, KR
AU  - Mayberry, JF
TI  - The risk of colorectal cancer in ulcerative colitis: a meta-analysis
J2  - Gut
PY  - 2001
VL  - 48
SP  - 526
EP  - 535
ER  - 
TY  - JOUR
LB  - 13.
AU  - Bishop, DT
AU  - Hall, NR
TI  - The genetics of colorectal cancer
J2  - Eur J Cancer
PY  - 1994
VL  - 30A
SP  - 1946
EP  - 1956
ER  - 
TY  - JOUR
LB  - 14.
AU  - Aaltonen, LA
AU  - Salovaara, R
AU  - Kristo, P
AU  - Canzian, F
AU  - Hemminki, A
AU  - Peltomaki, P
TI  - Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease
J2  - N Engl J Med
PY  - 1998
VL  - 338
SP  - 1481
EP  - 1487
ER  - 
TY  - JOUR
LB  - 15.
AU  - Jass, JR
AU  - Stewart, SM
TI  - Evolution of hereditary non-polyposis colorectal cancer
J2  - Gut
PY  - 1992
VL  - 33
SP  - 783
EP  - 786
ER  - 
TY  - JOUR
LB  - 16.
AU  - Vasen, HF
AU  - Mecklin, JP
AU  - Khan, PM
AU  - Lynch, HT
TI  - The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
J2  - Dis Colon Rectum
PY  - 1991
VL  - 34
SP  - 424
EP  - 425
ER  - 
TY  - JOUR
LB  - 17.
AU  - Muto, T
AU  - Bussey, HJ
AU  - Morson, BC
TI  - The evolution of cancer of the colon and rectum
J2  - Cancer
PY  - 1975
VL  - 36
SP  - 2251
EP  - 2270
ER  - 
TY  - JOUR
LB  - 18.
AU  - Hoff, G
AU  - Vatn, MH
TI  - Colonic adenoma: natural history
J2  - Dig Dis
PY  - 1991
VL  - 9
SP  - 61
EP  - 69
ER  - 
TY  - JOUR
LB  - 19.
AU  - Atkin, WS
AU  - Saunders, BP
TI  - Surveillance guidelines after removal of colorectal adenomatous polyps
J2  - Gut
PY  - 2002
VL  - 51
IS  - Suppl. 5
SP  - V6
EP  - V9
ER  - 
TY  - JOUR
LB  - 20.
AU  - Stryker, SJ
AU  - Wolff, BG
AU  - Culp, CE
AU  - Libbe, SD
AU  - Ilstrup, DM
AU  - MacCarty, RL
TI  - Natural history of untreated colonic polyps
J2  - Gastroenterology
PY  - 1987
VL  - 93
SP  - 1009
EP  - 1013
ER  - 
TY  - JOUR
LB  - 21.
AU  - Flossmann, E
AU  - Rothwell, PM
TI  - British Doctors Aspirin Trial and the UK-TIA Aspirin Trial. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
J2  - Lancet
PY  - 2007
VL  - 369
SP  - 1603
EP  - 1613
ER  - 
TY  - GEN
LB  - 22.
AU  - South West Cancer Intelligence Service
TI  - Data held on file: audit study of patients with colorectal cancer undertaken in the Wessex region 1991–1995
CY  - Bristol
PB  - South West Cancer Intelligence Service
PY  - 2005
ER  - 
TY  - ELEC
LB  - 23.
AU  - Cancer Research UK
TI  - Large bowel (colorectal) cancer factsheet
PY  - 2008
UR  - http://info.cancerresearchuk.org/cancerstats/types/bowel/?a=5441
ER  - 
TY  - JOUR
LB  - 24.
AU  - Van Cutsem, EJ
AU  - Kataja, VV
TI  - ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of colon cancer
J2  - Ann Oncol
PY  - 2005
VL  - 16
IS  - Suppl. 1
SP  - i16
EP  - i17
ER  - 
TY  - RPRT
LB  - 25.
AU  - Trueman, P
AU  - Chilcott, J
AU  - Tappenden, P
AU  - Lowson, K
AU  - Pilgrim, H
AU  - Bending, M
TI  - Bowel cancer services: costs and benefits. Report to the Department of Health
CY  - York
PB  - York Health Economics Consortium/Sheffield: School of Health and Related Research (University of Sheffield)
PY  - 2007
ER  - 
TY  - GEN
LB  - 26.
AU  - Association of Coloproctology of Great Britain and Ireland
TI  - Guidelines for the management of colorectal cancer
ET  - 3rd
CY  - London
PB  - Association of Coloproctology of Great Britain and Ireland
PY  - 2007
ER  - 
TY  - JOUR
LB  - 27.
AU  - Tappenden, P
AU  - Jones, R
AU  - Paisley, S
AU  - Carroll, C
TI  - Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer
J2  - Health Technol Assess
PY  - 2007
VL  - 11
IS  - 12
ER  - 
TY  - JOUR
LB  - 28.
AU  - Pandor, A
AU  - Eggington, S
AU  - Paisley, S
AU  - Tappenden, P
AU  - Sutcliffe, P
TI  - The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation
J2  - Health Technol Assess
PY  - 2006
VL  - 10
IS  - 41
ER  - 
TY  - JOUR
LB  - 29.
AU  - Ward, S
AU  - Kaltenthaler, E
AU  - Cowan, J
AU  - Brewer, N
TI  - Clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluation
J2  - Health Technol Assess
PY  - 2003
VL  - 7
IS  - 32
ER  - 
TY  - JOUR
LB  - 30.
AU  - Hind, D
AU  - Tappenden, P
AU  - Tumur, I
AU  - Eggington, S
AU  - Sutcliffe, P
AU  - Ryan, A
TI  - The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation
J2  - Health Technol Assess
PY  - 2008
VL  - 12
IS  - 15
ER  - 
TY  - JOUR
LB  - 31.
AU  - Murray, A
AU  - Lourenco, T
AU  - de Verteuil, R
AU  - Hernandez, R
AU  - Fraser, C
AU  - McKinley, A
TI  - Clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer: systematic reviews and economic evaluation
J2  - Health Technol Assess
PY  - 2006
VL  - 10
IS  - 45
ER  - 
TY  - BOOK
LB  - 32.
AU  - Phillips, RKS
TI  - Colorectal surgery
ET  - 3
CY  - London
PB  - Elsevier Saunders
PY  - 2005
ER  - 
TY  - JOUR
LB  - 33.
AU  - Tappenden, P
AU  - Chilcott, JB
AU  - Brennan, A
AU  - Pilgrim, H
TI  - Systematic review of economic evidence for the detection, diagnosis, treatment and follow-up of colorectal cancer in the UK
J2  - Int J Technol Assess Health Care
PY  - 2009
VL  - 25
SP  - 470
EP  - 478
ER  - 
TY  - JOUR
LB  - 34.
AU  - Towler, B
AU  - Irwig, L
AU  - Glasziou, P
AU  - Kewenter, J
AU  - Weller, D
AU  - Silagy, C
TI  - A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult
J2  - BMJ
PY  - 1998
VL  - 317
SP  - 559
EP  - 565
ER  - 
TY  - ELEC
LB  - 35.
AU  - National Health Service (NHS) UK
TI  - NHS Bowel Cancer Screening Programme website
PY  - 2009
UR  - www.cancerscreening.nhs.uk/bowel/
ER  - 
TY  - ELEC
LB  - 36.
AU  - Cancer Research, UK
TI  - Bowel cancer screening and prevention website
PY  - 2009
UR  - http://info.cancerresearchuk.org/cancerstats/types/bowel/screeningandprevention/
ER  - 
TY  - JOUR
LB  - 37.
AU  - Gatto, NM
AU  - Frucht, H
AU  - Sundararajan, V
AU  - Jacobson, JS
AU  - Grann, VR
AU  - Neugut, AI
TI  - Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study
J2  - J Natl Cancer Inst
PY  - 2003
VL  - 95
SP  - 230
EP  - 236
ER  - 
TY  - GEN
LB  - 38.
AU  - National Institute for Health and Clinical Excellence (NICE)
TI  - Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer
CY  - London
PB  - NICE
PY  - 2003
ER  - 
TY  - GEN
LB  - 39.
AU  - National Institute for Health and Clinical Excellence (NICE)
TI  - Guidance on the use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer
CY  - London
PB  - NICE
PY  - 2005
ER  - 
TY  - GEN
LB  - 40.
AU  - National Institute for Health and Clinical Excellence (NICE)
TI  - Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer
CY  - London
PB  - NICE
PY  - 2007
ER  - 
TY  - GEN
LB  - 41.
AU  - National Institute for Health and Clinical Excellence (NICE)
TI  - Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes’ C) colon cancer
CY  - London
PB  - NICE
PY  - 2006
ER  - 
TY  - GEN
LB  - 42.
AU  - National Institute for Health and Clinical Excellence (NICE)
TI  - Laparoscopic surgery for colorectal cancer.
CY  - London
PB  - NICE
PY  - 2006
ER  - 
TY  - JOUR
LB  - 43.
AU  - Lynch, PM
TI  - Chemoprevention with special reference to inherited colorectal cancer
J2  - Familial Cancer
PY  - 2008
VL  - 7
SP  - 59
EP  - 64
ER  - 
TY  - BOOK
LB  - 44.
AU  - Airey, C
AU  - Becher, H
AU  - Erens, B
AU  - Fuller, E
TI  - National surveys of NHS patients: cancer – national overview 1999/2000
CY  - London
PB  - Department of Health
PY  - 2002
ER  - 
TY  - JOUR
LB  - 45.
AU  - Villegas, I
AU  - Sanchez-Fidalgo, S
AU  - arcon de la, LC
TI  - New mechanisms and therapeutic potential of curcumin for colorectal cancer
J2  - Mol Nutr Food Res
PY  - 2008
VL  - 52
SP  - 1040
EP  - 1061
ER  - 
TY  - JOUR
LB  - 46.
AU  - Dupertuis, YMM
TI  - Colon cancer therapy: new perspectives of nutritional manipulations using polyunsaturated fatty acids
J2  - Curr Opin Clin Nutr Metabol Care
PY  - 2007
VL  - 10
SP  - 427
EP  - 432
ER  - 
TY  - GEN
LB  - 47.
AU  - European Medicines Agency (EMEA)
TI  - EMEA statement following withdrawal of Vioxx (rofecoxib)
PY  - 2004
UR  - http://www.emea.europa.eu/pdfs/human/press/pr/9794904en.pdf
CY  - London
PB  - EMEA
ER  - 
TY  - GEN
LB  - 48.
AU  - Asano, TK
AU  - McLeod, RS
TI  - Non steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomas. Cochrane Database Syst Rev
PY  - 2004
IS  - 2
ER  - 
TY  - JOUR
LB  - 49.
AU  - Dannenberg, AJ
AU  - Zakim, D
TI  - Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2
J2  - Semin Oncol
PY  - 1999
VL  - 26
SP  - 499
EP  - 504
ER  - 
TY  - JOUR
LB  - 50.
AU  - Gupta, RA
AU  - Dubois, RN
TI  - Translational studies on Cox-2 inhibitors in the prevention and treatment of colon cancer
J2  - Ann N Y Acad Sci
PY  - 2000
VL  - 910
SP  - 196
EP  - 204
ER  - 
TY  - JOUR
LB  - 51.
AU  - Bjelakovic, G
AU  - Nagorni, A
AU  - Nikolova, D
AU  - Simonetti, RG
AU  - Bjelakovic, M
AU  - Gluud, C
TI  - Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma
J2  - Aliment Pharmacol Therapeut
PY  - 2006
VL  - 24
SP  - 281
EP  - 291
ER  - 
TY  - JOUR
LB  - 52.
AU  - Maxwell, SR
TI  - Antioxidant vitamin supplements: update of their potential benefits and possible risks
J2  - Drug Saf
PY  - 1999
VL  - 21
SP  - 253
EP  - 266
ER  - 
TY  - JOUR
LB  - 53.
AU  - Diplock, AT
TI  - Antioxidants and disease prevention
J2  - Mol Aspects Med
PY  - 1994
VL  - 15
SP  - 293
EP  - 376
ER  - 
TY  - JOUR
LB  - 54.
AU  - Sporn, MB
AU  - Suh, N
TI  - Chemoprevention of cancer
J2  - Carcinogenesis
PY  - 2000
VL  - 21
SP  - 525
EP  - 530
ER  - 
TY  - JOUR
LB  - 55.
AU  - Lamprecht, SA
AU  - Lipkin, M
TI  - Chemoprevention of colon cancer by calcium, vitamin D and folate: Molecular mechanisms
J2  - Nat Rev Cancer
PY  - 2003
VL  - 3
SP  - 601
EP  - 614
ER  - 
TY  - ELEC
LB  - 56.
TI  - British National Formulary (BNF)
PY  - 2009
UR  - www.bnf.org
ER  - 
TY  - RPRT
LB  - 57.
AU  - European Medicines Agency (EMEA)
TI  - European public assessment report (EPAR): Onsenal: EPAR summary for the public
PY  - 2009
UR  - http://www.emea.europa.eu/humandocs/PDFs/EPAR/onsenal/370303en1.pdf
CY  - London
PB  - EMEA
ER  - 
TY  - JOUR
LB  - 58.
AU  - Lynch, PM
TI  - Prevention of colorectal cancer in high-risk populations: the increasing role for endoscopy and chemoprevention in FAP and HNPCC
J2  - Digestion
PY  - 2007
VL  - 76
SP  - 68
EP  - 76
ER  - 
TY  - JOUR
LB  - 59.
AU  - Atkin, W.S
AU  - Saunders, B
TI  - Surveillance guidelines after removal of colorectal adenomatous polyps
J2  - Gut
PY  - 2002
VL  - 51
IS  - Suppl. 5
SP  - v6
EP  - v9
ER  - 
TY  - JOUR
LB  - 60.
AU  - Logan, RF
AU  - Grainge, MJ
AU  - Shepherd, VC
AU  - Armitage, NC
AU  - Muir, KR
AU  - ukCAP Trial Group
TI  - Aspirin and folic acid for the prevention of recurrent colorectal adenomas
J2  - Gastroenterology
PY  - 2008
VL  - 134
SP  - 29
EP  - 38
ER  - 
TY  - JOUR
LB  - 61.
AU  - Cole, BF
AU  - Baron, JA
AU  - Sandler, RS
AU  - Haile, RW
AU  - Ahnen, DJ
AU  - Bresalier, RS
TI  - Folic acid for the prevention of colorectal adenomas: a randomized clinical trial
J2  - J Am Med Assoc
PY  - 2007
VL  - 297
SP  - 2351
EP  - 2359
ER  - 
TY  - JOUR
LB  - 62.
AU  - Benamouzig, R
AU  - Deyra, J
AU  - Martin, A
AU  - Girard, B
AU  - Jullian, E
AU  - Piednoir, B
TI  - Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial
J2  - Gastroenterology
PY  - 2003
VL  - 125
SP  - 328
EP  - 336
ER  - 
TY  - JOUR
LB  - 63.
AU  - Arber, N
AU  - Eagle, CJ
AU  - Spicak, J
AU  - Racz, I
AU  - Dite, P
AU  - Hajer, J
TI  - Celecoxib for the prevention of colorectal adenomatous polyps
J2  - N Engl J Med
PY  - 2006
VL  - 355
SP  - 885
EP  - 895
ER  - 
TY  - JOUR
LB  - 64.
AU  - Bertagnolli, MM
AU  - Eagle, CJ
AU  - Zauber, AG
AU  - Redston, M
AU  - Solomon, SD
AU  - Kim, K
TI  - Celecoxib for the prevention of sporadic colorectal adenomas
J2  - N Engl J Med
PY  - 2006
VL  - 355
SP  - 873
EP  - 884
ER  - 
TY  - JOUR
LB  - 65.
AU  - Moher, D
AU  - Cook, DJ
AU  - Eastwood, S
AU  - Olkin, I
AU  - Rennie, D
AU  - Stroup, DF
TI  - Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses
J2  - Lancet
PY  - 1999
VL  - 354
SP  - 1896
EP  - 1900
ER  - 
TY  - JOUR
LB  - 66.
AU  - Moher, D
AU  - Liberati, A
AU  - Tetzlaff, J
AU  - Altman, DG
TI  - Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
J2  - Ann Intern Med
PY  - 2009
VL  - 151
SP  - 264
EP  - 269
ER  - 
TY  - JOUR
LB  - 67.
AU  - Burn, J
AU  - Bishop, DT
AU  - Mecklin, JP
AU  - Macrae, F
AU  - Möslein, G
AU  - Olschwang, S
TI  - Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome
J2  - N Engl J Med
PY  - 2008
VL  - 359
SP  - 2567
EP  - 2578
ER  - 
TY  - JOUR
LB  - 68.
AU  - Cook, NR
AU  - Lee, IM
AU  - Gaziano, JM
AU  - Gordon, D
AU  - Ridker, PM
AU  - Manson, JE
TI  - Low-dose aspirin in the primary prevention of cancer: the Women’s Health Study: a randomized controlled trial
J2  - J Am Med Assoc
PY  - 2005
VL  - 294
SP  - 47
EP  - 55
ER  - 
TY  - JOUR
LB  - 69.
AU  - Ridker, PM
AU  - Cook, NR
AU  - Lee, IM
AU  - Gordon, D
AU  - Gaziano, JM
AU  - Manson, JE
TI  - A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women
J2  - N Engl J Med
PY  - 2005
VL  - 352
SP  - 1293
EP  - 1304
ER  - 
TY  - JOUR
LB  - 70.
AU  - Rexrode, KM
AU  - Lee, IM
AU  - Cook, NR
AU  - Hennekens, CH
AU  - Buring, JE
TI  - Baseline characteristics of participants in the Women’s Health Study
J2  - J Womens Health Gend Based Med
PY  - 2000
VL  - 9
SP  - 19
EP  - 27
ER  - 
TY  - JOUR
LB  - 71.
AU  - Burn, J
AU  - Chapman, PD
AU  - Bishop, DT
AU  - Dixon, R
AU  - Turner, F
AU  - Coaker, J
TI  - Results of the CAPP1 Study: aspirin and resistant starch are beneficial in familial adenomatous polyposis
J2  - Am J Hum Genet
PY  - 2003
VL  - 73
SP  - 202
ER  - 
TY  - JOUR
LB  - 72.
AU  - Mathers, JC
AU  - Mickleburgh, I
AU  - Chapman, PC
AU  - Bishop, DT
AU  - Burn, J
TI  - Can resistant starch and/or aspirin prevent the development of colonic neoplasia? The Concerted Action Polyp Prevention (CAPP) 1 Study
J2  - Proc Nutr Soc
PY  - 2003
VL  - 62
SP  - 51
EP  - 57
ER  - 
TY  - JOUR
LB  - 73.
AU  - Cole, BF
AU  - Baron, JA
AU  - Sandler, RS
AU  - Haile, RW
AU  - Ahnen, DJ
AU  - Bresalier, RS
TI  - A randomized trial of folic acid to prevent colorectal adenomas
J2  - Proceedings of the American Association for Cancer Research Annual Meeting
PY  - 2005
SP  - 46
ER  - 
TY  - JOUR
LB  - 74.
AU  - Baron, JA
AU  - Cole, BF
AU  - Sandler, RS
AU  - Haile, RW
AU  - Ahnen, D
AU  - Bresalier, R
TI  - A randomized trial of aspirin to prevent colorectal adenomas
J2  - N Engl J Med
PY  - 2003
VL  - 348
SP  - 891
EP  - 899
ER  - 
TY  - JOUR
LB  - 75.
AU  - Gann, PH
AU  - Manson, JE
AU  - Glynn, RJ
AU  - Buring, JE
AU  - Hennekens, CH
TI  - Low-dose aspirin and incidence of colorectal tumors in a randomized trial
J2  - J Natl Cancer Inst
PY  - 1993
VL  - 85
SP  - 1220
EP  - 1224
ER  - 
TY  - JOUR
LB  - 76.
AU  - Dube, C
AU  - Rostom, A
AU  - Lewin, G
AU  - Tsertsvadze, A
AU  - Barrowman, N
AU  - Code, C
TI  - The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force
J2  - Ann Intern Med
PY  - 2007
VL  - 146
SP  - 365
EP  - 375
ER  - 
TY  - JOUR
LB  - 77.
AU  - Farrell, B
AU  - Godwin, J
AU  - Richards, S
AU  - Warlow, C
TI  - The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results
J2  - J Neurol Neurosurg Psychiatry
PY  - 1991
VL  - 54
SP  - 1044
EP  - 1054
ER  - 
TY  - JOUR
LB  - 78.
AU  - Cole, BF
AU  - Logan, RF
AU  - Halabi, S
AU  - Benamouzig, R
AU  - Sandler, RS
AU  - Grainge, MJ
TI  - Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials
J2  - J Natl Cancer Inst
PY  - 2009
VL  - 101
SP  - 256
EP  - 266
ER  - 
TY  - JOUR
LB  - 79.
AU  - Sandler, RS
AU  - Halabi, S
AU  - Baron, JA
AU  - Budinger, S
AU  - Paskett, E
AU  - Keresztes, R
TI  - A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer
J2  - N Engl J Med
PY  - 2003
VL  - 348
SP  - 883
EP  - 890
ER  - 
TY  - JOUR
LB  - 80.
AU  - Peto, R
AU  - Gray, R
AU  - Collins, R
AU  - Wheatley, K
AU  - Hennekens, C
AU  - Jamrozik, K
TI  - Randomised trial of prophylactic daily aspirin in British male doctors
J2  - Br Med J (Clin Res Ed)
PY  - 1988
VL  - 296
SP  - 313
EP  - 316
ER  - 
TY  - JOUR
LB  - 81.
AU  - Gao, F
AU  - Liao, C
AU  - Liu, L
AU  - Tan, A
AU  - Cao, Y
AU  - Mo, Z
TI  - The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials
J2  - Colorectal Dis
PY  - 2008
VL  - 11
SP  - 893
EP  - 901
ER  - 
TY  - JOUR
LB  - 82.
AU  - Wang, Y-P
AU  - Pan, T
AU  - Yang, J-L
AU  - Wang, Q
AU  - Gan, T
TI  - Nonsteroidal anti-inflammatory drugs for prevention of colorectal neoplasms: a systematic review
J2  - Chinese J Evidence-Based Med
PY  - 2005
VL  - 5
SP  - 438
EP  - 443
ER  - 
TY  - JOUR
LB  - 83.
AU  - Giardiello, FM
AU  - Yang, VW
AU  - Hylind, LM
AU  - Krush, AJ
AU  - Petersen, GM
AU  - Trimbath, JD
TI  - Primary chemoprevention of familial adenomatous polyposis with sulindac
J2  - N Engl J Med
PY  - 2002
VL  - 346
SP  - 1054
EP  - 1059
ER  - 
TY  - JOUR
LB  - 84.
AU  - Solomon, SD
AU  - Pfeffer, MA
AU  - McMurray, JJ
AU  - Fowler, R
AU  - Finn, P
AU  - Levin, B
TI  - Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas
J2  - Circulation
PY  - 2006
VL  - 114
SP  - 1028
EP  - 1035
ER  - 
TY  - JOUR
LB  - 85.
AU  - Iwama, T
AU  - Akasu, T
AU  - Utsunomiya, J
AU  - Muto, T
TI  - Does a selective cyclooxygenase-2 inhibitor (tiracoxib) induce clinically sufficient suppression of adenomas in patients with familial adenomatous polyposis? A randomized double-blind placebo-controlled clinical trial
J2  - Int J Clin Oncol
PY  - 2006
VL  - 11
SP  - 133
EP  - 139
ER  - 
TY  - JOUR
LB  - 86.
AU  - Solomon, SD
AU  - McMurray, JJ
AU  - Pfeffer, MA
AU  - Wittes, J
AU  - Fowler, R
AU  - Finn, P
TI  - Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
J2  - N Engl J Med
PY  - 2005
VL  - 352
SP  - 1071
EP  - 1080
ER  - 
TY  - JOUR
LB  - 87.
AU  - Brophy, JM
AU  - Solomon, SD
AU  - Wittes, J
AU  - McMurray, J
AU  - Psaty, BM
AU  - Furberg, CD
TI  - Cardiovascular risk associated with celecoxib
J2  - N Engl J Med
PY  - 2005
VL  - 352
SP  - 2648
EP  - 2650
ER  - 
TY  - JOUR
LB  - 88.
AU  - Rostom, A
AU  - Dube, C
AU  - Lewin, G
AU  - Tsertsvadze, A
AU  - Barrowman, N
AU  - Code, C
TI  - Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force
J2  - Ann Intern Med
PY  - 2007
VL  - 146
SP  - 376
EP  - 389
ER  - 
TY  - JOUR
LB  - 89.
AU  - Steinbach, G
AU  - Lynch, PM
AU  - Phillips, RK
AU  - Wallace, MH
AU  - Hawk, E
AU  - Gordon, GB
TI  - The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
J2  - N Engl J Med
PY  - 2000
VL  - 342
SP  - 1946
EP  - 1952
ER  - 
TY  - JOUR
LB  - 90.
AU  - Ladenheim, J
AU  - Garcia, G
AU  - Titzer, D
AU  - Herzenberg, H
AU  - Lavori, P
AU  - Edson, R
TI  - Effect of sulindac on sporadic colonic polyps
J2  - Gastroenterology
PY  - 1995
VL  - 108
SP  - 1083
EP  - 1087
ER  - 
TY  - JOUR
LB  - 91.
AU  - Giardiello, FM
AU  - Hamilton, SR
AU  - Krush, AJ
AU  - Piantadosi, S
AU  - Hylind, LM
AU  - Celano, P
TI  - Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
J2  - N Engl J Med
PY  - 1993
VL  - 328
SP  - 1313
EP  - 1316
ER  - 
TY  - JOUR
LB  - 92.
AU  - Abir, F
AU  - Alva, S
AU  - Kaminski, DL
AU  - Longo, WE
TI  - The role of arachidonic acid regulatory enzymes in colorectal disease
J2  - Dis Colon Rectum
PY  - 2005
VL  - 48
SP  - 1471
EP  - 1483
ER  - 
TY  - JOUR
LB  - 93.
AU  - Nugent, KP
AU  - Farmer, KCR
AU  - Spigelman, AD
AU  - Williams, CB
AU  - Phillips, RKS
TI  - Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis
J2  - Br J Surg
PY  - 1993
VL  - 80
SP  - 1618
EP  - 1619
ER  - 
TY  - JOUR
LB  - 94.
AU  - Labayle, D
AU  - Fischer, D
AU  - Vielh, P
AU  - Drouhin, F
AU  - Pariente, A
AU  - Bories, C
TI  - Sulindac causes regression of rectal polyps in familial adenomatous polyposis
J2  - Gastroenterology
PY  - 1991
VL  - 101
SP  - 635
EP  - 639
ER  - 
TY  - JOUR
LB  - 95.
AU  - Thomas, MG
AU  - Thomson, JP
AU  - Williamson, RC
AU  - Thomas, MG
AU  - Thomson, JP
AU  - Williamson, RC
TI  - Oral calcium inhibits rectal epithelial proliferation in familial adenomatous polyposis
J2  - Br J Surg
PY  - 1993
VL  - 80
SP  - 499
EP  - 501
ER  - 
TY  - JOUR
LB  - 96.
AU  - Bonithon-Kopp, C
AU  - Kronborg, O
AU  - Giacosa, A
AU  - Rath, U
AU  - Faivre, J
AU  - Bonithon-Kopp, C
TI  - Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group
J2  - Lancet
PY  - 2000
VL  - 356
SP  - 1300
EP  - 1306
ER  - 
TY  - JOUR
LB  - 97.
AU  - Lappe, JMT
TI  - Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial
J2  - Am J Clin Nutr
PY  - 2007
VL  - 85
SP  - 1586
EP  - 1591
ER  - 
TY  - JOUR
LB  - 98.
AU  - Weingarten, MA
AU  - Zalmanovici, A
AU  - Yaphe, J
TI  - Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
J2  - Cochrane Database Syst Rev
PY  - 2008
IS  - 1
ER  - 
TY  - JOUR
LB  - 99.
AU  - Baron, J
AU  - Beach, M
AU  - Mandel, J
AU  - van Stolk, R
AU  - Haile, R
AU  - Sandler, R
TI  - Calcium supplements for the prevention of colorectal adenomas
J2  - N Engl J Med
PY  - 1999
VL  - 340
SP  - 101
EP  - 107
ER  - 
TY  - JOUR
LB  - 100.
AU  - Baron, JA
AU  - Beach, M
AU  - Mandel, JS
AU  - van Stolk, RU
AU  - Haile, RW
AU  - Sandler, RS
TI  - Calcium supplements and colorectal adenomas. Polyp Prevention Study Group
J2  - Ann N Y Acad Sci
PY  - 1999
VL  - 889
SP  - 138
EP  - 145
ER  - 
TY  - JOUR
LB  - 101.
AU  - Wactawski-Wende, J
AU  - Kotchen, JM
AU  - Anderson, GL
AU  - Assaf, AR
AU  - Brunner, RL
AU  - O’Sullivan, MJ
TI  - Calcium plus vitamin D supplementation and the risk of colorectal cancer
J2  - N Engl J Med
PY  - 2006
VL  - 354
SP  - 684
EP  - 696
ER  - 
TY  - JOUR
LB  - 102.
AU  - Shaukat, A
AU  - Scouras, N
AU  - Schunemann, HJ
TI  - Role of supplemental calcium in the recurrence of colorectal adenomas: a metaanalysis of randomized controlled trials
J2  - Am J Gastroenterol
PY  - 2005
VL  - 100
SP  - 390
EP  - 394
ER  - 
TY  - JOUR
LB  - 103.
AU  - Hofstad, B
AU  - Almendingen, K
AU  - Vatn, M
AU  - Andersen, SN
AU  - Owen, RW
AU  - Larsen, S
TI  - Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants
J2  - Digestion
PY  - 1998
VL  - 59
SP  - 148
EP  - 156
ER  - 
TY  - JOUR
LB  - 104.
AU  - Hofstad, B
AU  - Vatn, M
AU  - Hoff, G
AU  - Larsen, S
AU  - Osnes, M
AU  - Hofstad, B
TI  - Growth of colorectal polyps: design of a prospective, randomized, placebo-controlled intervention study in patients with colorectal polyps
J2  - Eur J Cancer Prev
PY  - 1992
VL  - 1
SP  - 415
EP  - 422
ER  - 
TY  - JOUR
LB  - 105.
AU  - Zhang, SM
AU  - Cook, NR
AU  - Albert, CM
AU  - Gaziano, JM
AU  - Buring, JE
AU  - Manson, JE
TI  - Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial
J2  - J Am Med Assoc
PY  - 2008
VL  - 300
SP  - 2012
EP  - 2021
ER  - 
TY  - JOUR
LB  - 106.
AU  - Lonn, E
AU  - Yusuf, S
AU  - Arnold, M
AU  - Sheridan, P
AU  - Pogue, J
AU  - Micks, M
TI  - for the HOPE-2 investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease
J2  - N Engl J Med
PY  - 2006
VL  - 354
SP  - 1567
EP  - 1577
ER  - 
TY  - JOUR
LB  - 107.
AU  - Lonn, E
AU  - Yusuf, S
AU  - Arnold, M
AU  - Sheridan, P
AU  - Pogue, J
AU  - Micks, M
TI  - for the HOPE-Z investigators. Rationale, design and baseline characteristics of a large, simple, randomised trial of combined folic acid and vitamin B6 and B12, in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial
J2  - Can J Cardiol
PY  - 2006
VL  - 22
SP  - 47
EP  - 53
ER  - 
TY  - JOUR
LB  - 108.
AU  - Jaszewski, R
AU  - Misra, S
AU  - Tobi, M
AU  - Ullah, N
AU  - Naumoff, JA
AU  - Kucuk, O
TI  - Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial
J2  - World J Gastroenterol
PY  - 2008
VL  - 14
SP  - 4492
EP  - 4498
ER  - 
TY  - JOUR
LB  - 109.
AU  - Zhu, S
AU  - Mason, J
AU  - Shi, Y
AU  - Hu, Y
AU  - Li, R
AU  - Wahg, M
TI  - The effect of folic acid on the development of stomach and other gastrointestinal cancers
J2  - Chin Med J
PY  - 2003
VL  - 116
SP  - 15
EP  - 19
ER  - 
TY  - JOUR
LB  - 110.
AU  - Zhu, S
AU  - Mason, J
AU  - Shi, Y
AU  - Hu, Y
AU  - Li, R
AU  - Wang, M
TI  - The interventional effect of folic acid on the development of gastric and other gastrointestinal cancers – clinical trial and follow-up for seven years
J2  - Chin J Gastroenterol
PY  - 2002
VL  - 7
SP  - 73
EP  - 78
ER  - 
TY  - JOUR
LB  - 111.
AU  - Baron, JA
AU  - Cole, BF
AU  - Mott, L
AU  - Haile, R
AU  - Grau, M
AU  - Church, TR
TI  - Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: results of a randomized trial
J2  - J Natl Cancer Inst
PY  - 2003
VL  - 95
SP  - 717
EP  - 722
ER  - 
TY  - JOUR
LB  - 112.
AU  - Greenberg, ER
AU  - Baron, JA
AU  - Tosteson, TD
AU  - Freeman, DH, Jr
AU  - Beck, GJ
AU  - Bond, JH
TI  - A clinical trial of antioxidant vitamins to prevent colorectal adenoma
J2  - Polyp Prevention Study Group N Engl J Med
PY  - 1994
VL  - 331
SP  - 141
EP  - 147
ER  - 
TY  - JOUR
LB  - 113.
AU  - Gaziano, JM
AU  - Glynn, RJ
AU  - Christen, WG
AU  - Kurth, T
AU  - Belanger, C
AU  - MacFadyen, J
TI  - Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians’ Health Study II randomized controlled trial
J2  - J Am Med Assoc
PY  - 2009
VL  - 301
SP  - 52
EP  - 62
ER  - 
TY  - JOUR
LB  - 114.
AU  - Bjelakovic, G
AU  - Nikolova, D
AU  - Simonetti, RG
AU  - Gluud, C
TI  - Antioxidant supplements for preventing gastrointestinal cancers
J2  - Cochrane Database Syst Rev
PY  - 2008
IS  - 4
ER  - 
TY  - EDBOOK
LB  - 115.
AU  - Palmieri, Y
TI  - Reduction of the incidence of metachronous adenomas of the large bowel by means of antioxidants
CY  - Brussels
PB  - Se-Te Press
PY  - 1998
ER  - 
TY  - JOUR
LB  - 116.
AU  - Lippman, SM
AU  - Klein, EA
AU  - Goodman, PJ
AU  - Lucia, MS
AU  - Thompson, IM
AU  - Ford, LG
TI  - Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
J2  - J Am Med Assoc
PY  - 2009
VL  - 301
SP  - 39
EP  - 51
ER  - 
TY  - JOUR
LB  - 117.
AU  - Bjelakovic, G
AU  - Nikolova, D
AU  - Simonetti, RG
AU  - Gluud, C
TI  - Systematic review: primary and secondary prevention of gastrointestinal cancers with antioxidant supplements
J2  - Aliment Pharmacol Ther
PY  - 2008
VL  - 28
SP  - 689
EP  - 703
ER  - 
TY  - JOUR
LB  - 118.
AU  - Lin, J
AU  - Cook, NR
AU  - Albert, C
AU  - Zaharris, E
AU  - Gaziano, JM
AU  - Van, DM
TI  - Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial
J2  - J Natl Cancer Inst
PY  - 2009
VL  - 101
SP  - 14
EP  - 23
ER  - 
TY  - JOUR
LB  - 119.
AU  - Cook, NR
AU  - Albert, CM
AU  - Gaziano, JM
AU  - Zaharris, E
AU  - MacFadyen, J
AU  - Danielson, E
TI  - A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women’s Antioxidant Cardiovascular Study
J2  - Arch Intern Med
PY  - 2007
VL  - 167
SP  - 1610
EP  - 1618
ER  - 
TY  - JOUR
LB  - 120.
AU  - Manson, JE
AU  - Gaziano, JM
AU  - Spelsberg, A
AU  - Ridker, PM
AU  - Cook, NR
AU  - Buring, JE
TI  - A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. The WACS Research Group
J2  - Ann Epidemiol
PY  - 1995
VL  - 5
SP  - 261
EP  - 269
ER  - 
TY  - JOUR
LB  - 121.
AU  - Ponz de Leon, M
AU  - Roncucci, L
TI  - Chemoprevention of colorectal tumors: role of lactulose and of other agents
J2  - Scand J Gastroenterol Suppl
PY  - 1997
VL  - 222
SP  - 72
EP  - 75
ER  - 
TY  - JOUR
LB  - 122.
AU  - Lee, IM
AU  - Cook, NR
AU  - Gaziano, JM
AU  - Gordon, D
AU  - Ridker, PM
AU  - Manson, JE
TI  - Vitamin E in the primary prevention of cardiovascular disease and cancer. The women’s health study: a randomized controlled trial
J2  - J Am Med Assoc
PY  - 2005
VL  - 294
SP  - 56
EP  - 65
ER  - 
TY  - JOUR
LB  - 123.
AU  - Lee, IM
AU  - Cook, NR
AU  - Manson, JE
AU  - Buring, JE
AU  - Hennekens, CH
TI  - Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women’s Health Study
J2  - J Natl Cancer Inst
PY  - 1999
VL  - 91
SP  - 2102
EP  - 2106
ER  - 
TY  - JOUR
LB  - 124.
AU  - Roncucci, L
AU  - Di, DP
AU  - Carati, L
AU  - Ferrari, A
AU  - Perini, M
AU  - Bertoni, G
TI  - Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Colorectal Cancer Study Group of the University of Modena and the Health Care District 16
J2  - Dis Colon Rectum
PY  - 1993
VL  - 36
SP  - 227
EP  - 234
ER  - 
TY  - JOUR
LB  - 125.
AU  - Lonn, E
AU  - Bosch, J
AU  - Yusuf, S
AU  - Sheridan, P
AU  - Pogue, J
AU  - Arnold, JM
TI  - Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial
J2  - J Am Med Assoc
PY  - 2005
VL  - 293
SP  - 1338
EP  - 1347
ER  - 
TY  - JOUR
LB  - 126.
AU  - MacLennan, R
AU  - Macrae, F
AU  - Bain, C
AU  - Battistutta, D
AU  - Chapuis, P
AU  - Gratten, H
TI  - Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas
J2  - J Natl Cancer Inst
PY  - 1995
VL  - 87
SP  - 1760
EP  - 1766
ER  - 
TY  - JOUR
LB  - 127.
AU  - Goodman, GE
AU  - Thornquist, MD
AU  - Balmes, J
AU  - Cullen, MR
AU  - Meyskens, FL, Jr
AU  - Omenn, GS
TI  - The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements
J2  - J Natl Cancer Inst
PY  - 2004
VL  - 96
SP  - 1743
EP  - 1750
ER  - 
TY  - JOUR
LB  - 128.
AU  - Omenn, GS
AU  - Goodman, GE
AU  - Thornquist, MD
AU  - Balmes, J
AU  - Cullen, MR
AU  - Glass, A
TI  - Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial
J2  - J Natl Cancer Inst
PY  - 1996
VL  - 88
SP  - 1550
EP  - 1559
ER  - 
TY  - JOUR
LB  - 129.
AU  - McKeown-Eyssen, G
AU  - Holloway, C
AU  - Jazmaji, V
AU  - Bright-See, E
AU  - Dion, P
AU  - Bruce, WR
TI  - A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps
J2  - Cancer Res
PY  - 1988
VL  - 48
SP  - 4701
EP  - 4705
ER  - 
TY  - JOUR
LB  - 130.
AU  - Hercberg, S
AU  - Galan, P
AU  - Preziosi, P
AU  - Bertrais, S
AU  - Mennen, L
AU  - Malvy, D
TI  - The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals
J2  - Arch Intern Med
PY  - 2004
VL  - 164
SP  - 2335
EP  - 2342
ER  - 
TY  - JOUR
LB  - 131.
AU  - Hercberg, S
AU  - Czernichow, S
AU  - Galan, P
TI  - Antioxidant vitamins and minerals in prevention of cancers: lessons from the SU.VI.MAX study
J2  - Br J Nutr
PY  - 2006
VL  - 96
IS  - Suppl. 1
SP  - S28
EP  - S30
ER  - 
TY  - JOUR
LB  - 132.
AU  - Hercberg, S
AU  - Preziosi, P
AU  - Briancon, S
AU  - Galan, P
AU  - Triol, I
AU  - Malvy, D
TI  - A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study – design, methods, and participant characteristics. SUpplementation en VItamines et Mineraux AntioXydants
J2  - Control Clin Trials
PY  - 1998
VL  - 19
SP  - 336
EP  - 351
ER  - 
TY  - JOUR
LB  - 133.
AU  - Virtamo, J
AU  - Pietinen, P
AU  - Huttunen, JK
AU  - Korhonen, P
AU  - Malila, N
AU  - Virtanen, MJ
TI  - Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up
J2  - J Am Med Assoc
PY  - 2003
VL  - 290
SP  - 476
EP  - 485
ER  - 
TY  - JOUR
LB  - 134.
AU  - Malila, N
AU  - Virtamo, J
AU  - Virtanen, M
AU  - Albanes, D
AU  - Tangrea, JA
AU  - Huttunen, JK
TI  - The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers
J2  - Cancer Epidemiol Biomarkers Prev
PY  - 1999
VL  - 8
SP  - 489
EP  - 493
ER  - 
TY  - JOUR
LB  - 135.
AU  - Albanes, D
AU  - Malila, N
AU  - Taylor, PR
AU  - Huttunen, JK
AU  - Virtamo, J
AU  - Edwards, BK
TI  - Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland)
J2  - Cancer Causes Control
PY  - 2000
VL  - 11
SP  - 197
EP  - 205
ER  - 
TY  - JOUR
LB  - 136.
AU  - Albanes, D
AU  - Heinonen, OP
AU  - Huttunen, JK
AU  - Taylor, PR
AU  - Virtamo, J
AU  - Edwards, BK
TI  - Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study
J2  - Am J Clin Nutr
PY  - 1995
VL  - 62
IS  - Suppl. 6
SP  - 1427S
EP  - 1430S
ER  - 
TY  - JOUR
LB  - 137.
AU  - Duffield-Lillico, AJ
AU  - Reid, ME
AU  - Turnbull, BW
AU  - Combs, GF
AU  - Jr, Slate, EH
AU  - Fischbach, LA
TI  - Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial
J2  - Cancer Epidemiol Biomarkers Prev
PY  - 2002
VL  - 11
SP  - 630
EP  - 639
ER  - 
TY  - JOUR
LB  - 138.
AU  - Reid, ME
AU  - Duffield-Lillico, AJ
AU  - Sunga, A
AU  - Fakih, M
AU  - Alberts, DS
AU  - Marshall, JR
TI  - Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial
J2  - Int J Cancer
PY  - 2006
VL  - 118
SP  - 1777
EP  - 1781
ER  - 
TY  - JOUR
LB  - 139.
AU  - Clark, LC
AU  - Combs, GF
AU  - Jr, Turnbull, BW
AU  - Slate, EH
AU  - Chalker, DK
AU  - Chow, J
TI  - Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group
J2  - J Am Med Assoc
PY  - 1996
VL  - 276
SP  - 1957
EP  - 1963
ER  - 
TY  - JOUR
LB  - 140.
AU  - Heart Protection Study Collaborative Group
TI  - MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial
J2  - Lancet
PY  - 2002
VL  - 360
SP  - 23
EP  - 33
ER  - 
TY  - JOUR
LB  - 141.
AU  - Heart Protection Study Collaborative Group
TI  - MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial
J2  - Lancet
PY  - 2002
VL  - 360
SP  - 7
EP  - 22
ER  - 
TY  - JOUR
LB  - 142.
AU  - Hennekens, CH
AU  - Buring, JE
AU  - Manson, JE
AU  - Stampfer, M
AU  - Rosner, B
AU  - Cook, NR
TI  - Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
J2  - N Engl J Med
PY  - 1996
VL  - 334
SP  - 1145
EP  - 1149
ER  - 
TY  - ELEC
LB  - 143.
AU  - Burn, J
AU  - Mathers, JC
AU  - Gerdes, AM
AU  - Bisgaard, ML
AU  - Evans, G
AU  - Eccles, D
TI  - Cancer occurrence during follow-up of the CAPP2 Study – Aspirin use for up to four years significantly reduces Lynch syndrome cancers for up to 10 years. InSiGHT Conference
PY  - 2009
UR  - http://www.capp2.com/newsZone/readnews.php?NewsID=45
ER  - 
TY  - JOUR
LB  - 144.
AU  - Benamouzig, R
AU  - Deyra, J
AU  - Martin, A
AU  - Bejou, B
AU  - Raynaud, JJ
AU  - Girard, B
TI  - Daily soluble aspirin and prevention of colorectal adenoma recurrence four years results of the APACC trial
J2  - Gastroenterology
PY  - 2006
VL  - 130
SP  - A101
ER  - 
TY  - JOUR
LB  - 145.
AU  - Antithrombotic Trialists’ (ATT) Collaboration
TI  - Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
J2  - Lancet
PY  - 2009
VL  - 373
SP  - 1849
EP  - 1860
ER  - 
TY  - JOUR
LB  - 146.
AU  - Sheng, JQ
AU  - Li, SR
AU  - Yang, XY
AU  - Zhang, YH
AU  - Su, H
AU  - Yu, DL
TI  - Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis
J2  - Chung-Hua i Hsueh Tsa Chih [Chin Med J]
PY  - 2006
VL  - 86
SP  - 526
EP  - 529
ER  - 
TY  - JOUR
LB  - 147.
AU  - Higuchi, T
AU  - Iwama, T
AU  - Yoshinaga, K
AU  - Toyooka, M
AU  - Taketo, MM
AU  - Sugihara, K
TI  - A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients
J2  - Clin Cancer Res
PY  - 2003
VL  - 9
SP  - 4756
EP  - 4760
ER  - 
TY  - JOUR
LB  - 148.
AU  - Wood, NJ
AU  - Quinton, NA
AU  - Burdall, S
AU  - Sheridan, E
AU  - Duffy, SR
TI  - Exploring the potential chemopreventative effect of aspirin and rofecoxib on hereditary nonpolyposis colorectal cancer-like endometrial cancer cells in vitro through mechanisms involving apoptosis, the cell cycle, and mismatch repair gene expression
J2  - Int J Gynecol Cancer
PY  - 2007
VL  - 17
SP  - 447
EP  - 454
ER  - 
TY  - JOUR
LB  - 149.
AU  - De Vries, E
AU  - Cats, A
AU  - van der Meer, R
AU  - Mulder, N
AU  - Hardonk, M
AU  - Kleibeuker, J
TI  - Randomized, double-blind, placebo-controlled study with calcium in heredity nonpolyposis colorectal cancer (HNPCC)
J2  - Proc Am Assoc Cancer Res Annual Meeting
PY  - 1994
VL  - 35
SP  - 622
ER  - 
TY  - JOUR
LB  - 150.
AU  - Seow-Choen, F
AU  - Vijayan, V
AU  - Keng, V
AU  - Seow-Choen, F
AU  - Vijayan, V
AU  - Keng, V
TI  - Prospective randomized study of sulindac versus calcium and calciferol for upper gastrointestinal polyps in familial adenomatous polyposis
J2  - Br J Surg
PY  - 1996
VL  - 83
SP  - 1763
EP  - 1766
ER  - 
TY  - JOUR
LB  - 151.
AU  - Sinicrope, FA
AU  - Half, E
AU  - Morris, JS
AU  - Lynch, PM
AU  - Morrow, JD
AU  - Levin, B
TI  - Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients
J2  - Cancer Epidemiol Biomarkers Prev
PY  - 2004
VL  - 13
SP  - 920
EP  - 927
ER  - 
TY  - JOUR
LB  - 152.
AU  - Chen, HP
AU  - Han, SX
AU  - Zeng, LM
AU  - Xu, G
AU  - Yang, H
TI  - Sulindac for treatment of colorectal adenomas
J2  - Chin J Dig
PY  - 2001
VL  - 21
SP  - 340
EP  - 341
ER  - 
TY  - JOUR
LB  - 153.
AU  - Baron, JA
AU  - Sandler, RS
AU  - Bresalier, RS
AU  - Quan, H
AU  - Riddell, R
AU  - Lanas, A
TI  - A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas
J2  - Gastroenterology
PY  - 2006
VL  - 131
SP  - 1674
EP  - 1682
ER  - 
TY  - JOUR
LB  - 154.
AU  - Meyskens, FL
AU  - McLaren, CE
AU  - Pelot, D
AU  - Fujikawa-Brooks, S
AU  - Carpenter, PM
AU  - Hawk, E
TI  - Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial
J2  - Cancer Prev Res Philad PA
PY  - 2008
VL  - 1
SP  - 9
EP  - 11
ER  - 
TY  - JOUR
LB  - 155.
AU  - Grau, MV
AU  - Baron, JA
AU  - Sandler, RS
AU  - Wallace, K
AU  - Haile, RW
AU  - Church, TR
TI  - Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial
J2  - J Natl Cancer Inst
PY  - 2007
VL  - 99
SP  - 129
EP  - 136
ER  - 
TY  - JOUR
LB  - 156.
AU  - Bjelakovic, G
AU  - Nikolova, D
AU  - Gluud, LL
AU  - Simonetti, RG
AU  - Gluud, C
TI  - Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
J2  - Cochrane Database Syst Rev
PY  - 2008
IS  - 2
ER  - 
TY  - JOUR
LB  - 157.
AU  - Jass, JR
TI  - Limitations of the adenoma-carcinoma sequence in colorectum
J2  - Clin Cancer Res
PY  - 2004
VL  - 10
SP  - 5969
EP  - 5970
ER  - 
TY  - JOUR
LB  - 158.
AU  - Winawer, SJ
AU  - Zauber, AG
AU  - Ho, MN
AU  - O’Brien, MJ
AU  - Gottlieb, LS
AU  - Sternberg, SS
TI  - Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup
J2  - N Engl J Med
PY  - 1993
VL  - 329
SP  - 1977
EP  - 1981
ER  - 
TY  - JOUR
LB  - 159.
AU  - Giovannucci, E
AU  - Stampfer, MJ
AU  - Colditz, GA
AU  - Hunter, DJ
AU  - Fuchs, C
AU  - Rosner, BA
TI  - Multivitamin use, folate, and colon cancer in women in the nurses’ health study
J2  - Ann Intern Med
PY  - 1998
VL  - 129
SP  - 517
EP  - 524
ER  - 
TY  - JOUR
LB  - 160.
AU  - Virtamo, J
AU  - Valkeila, E
AU  - Alfthan, G
AU  - Punsar, S
AU  - Huttunen, JK
AU  - Karvonen, MJ
TI  - Serum selenium and risk of cancer. A prospective follow-up of nine years
J2  - Cancer
PY  - 1987
VL  - 60
SP  - 145
EP  - 148
ER  - 
TY  - JOUR
LB  - 161.
AU  - West, NJ
AU  - Clark, SK
AU  - Belluzzi, A
AU  - Hutchinson, JM
AU  - Hull, MA
AU  - Leicester, RJ
TI  - Chemopreventive effect of eicosapentaenoic acid (EPA) free fatty acid in familial adenomatous polyposis (FAP): results of a randomised, placebo-controlled trial
J2  - Gut
PY  - 2009
VL  - 58
IS  - Suppl. 2
SP  - A1
ER  - 
TY  - JOUR
LB  - 162.
AU  - Poynter, JN
AU  - Gruber, SB
AU  - Higgins, PD
AU  - Almog, R
AU  - Bonner, JD
AU  - Rennert, HS
J2  - Statins and the risk of colorectal cancer N Engl J Med
PY  - 2005
VL  - 352
SP  - 2184
EP  - 2192
ER  - 
TY  - JOUR
LB  - 163.
AU  - Hachem, C
AU  - Morgan, R
AU  - Johnson, M
AU  - Kuebeler, M
AU  - El-Serag, H
TI  - Statins and the risk of colorectal carcinoma: a nested case–control study in veterans with diabetes
J2  - Am J Gastroenterol
PY  - 2009
VL  - 104
SP  - 1241
EP  - 1248
ER  - 
TY  - JOUR
LB  - 164.
AU  - Shepherd, J
AU  - Blauw, GJ
AU  - Murphy, MB
AU  - Bollen, EL
AU  - Buckley, BM
AU  - Cobbe, SM
TI  - Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J2  - Lancet
PY  - 2002
VL  - 360
SP  - 1623
EP  - 1630
ER  - 
TY  - JOUR
LB  - 165.
AU  - Goldstein, MR
AU  - Mascitelli, L
AU  - Pezzetta, F
TI  - Statins and colorectal cancer: the jury is still out
J2  - Am J Gastroenterol
PY  - 2009
VL  - 104
SP  - 2858
EP  - 2859
ER  - 
TY  - JOUR
LB  - 166.
AU  - Wilczynski, N
AU  - Marks, S
AU  - Haynes, RB
TI  - Search strategies for identifying qualitative studies in CINAHL
J2  - Qual Health Res
PY  - 2007
VL  - 17
SP  - 705
EP  - 710
ER  - 
TY  - JOUR
LB  - 167.
AU  - Tedstone, A
AU  - Browne, M
AU  - Harrop, L
AU  - Vernon, C
AU  - Page, V
AU  - Swindells, J
TI  - Fortification of selected foodstuffs with folic acid in the UK: consumer research carried out to inform policy recommendations
J2  - J Public Health
PY  - 2008
VL  - 30
SP  - 23
EP  - 29
ER  - 
TY  - JOUR
LB  - 168.
AU  - Townsend, A
AU  - Hunt, K
AU  - Wyke, S
TI  - Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use
J2  - BMJ
PY  - 2003
VL  - 327
SP  - 837
EP  - 840
ER  - 
TY  - JOUR
LB  - 169.
AU  - Wazaify, M
AU  - Shields, E
AU  - Hughes, CM
AU  - McElnay, JC
TI  - Societal perspectives on over-the-counter (OTC) medicines
J2  - Family Practice
PY  - 2005
VL  - 22
SP  - 170
EP  - 176
ER  - 
TY  - JOUR
LB  - 170.
AU  - Carnes, D
AU  - Anwer, Y
AU  - Underwood, M
AU  - Harding, G
AU  - Parsons, S
TI  - and the TOIB study team. Influences on older people’s decision making regarding choice of topical or oral NSAIDs for knee pain: qualitative study
J2  - BMJ
PY  - 2008
VL  - 336
SP  - 142
EP  - 145
ER  - 
TY  - JOUR
LB  - 171.
AU  - French, DP
AU  - James, DH
TI  - Reasons for the use of mild analgesics among English students
J2  - Pharm World Sci
PY  - 2008
VL  - 30
SP  - 79
EP  - 85
ER  - 
TY  - JOUR
LB  - 172.
AU  - Tong, A
AU  - Sainsbury, P
AU  - Craig, J
TI  - Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups
J2  - Int J Qual Health Care
PY  - 2007
VL  - 19
SP  - 349
EP  - 357
ER  - 
TY  - CONF
LB  - 173.
AU  - Atkins, C
AU  - Sampson, J
TI  - Critical appraisal guidelines for single case study research
T2  - Proceedings of ECIS 2002, the Xth European Conference on Information Systems
CY  - Gdansk
DA  - 6–8 June. 2002
ER  - 
TY  - JOUR
LB  - 174.
AU  - Boynton, P
TI  - Hands-on guide to questionnaire research: selecting, designing, and developing your questionnaire
J2  - BMJ
PY  - 2004
VL  - 328
SP  - 1312
ER  - 
TY  - JOUR
LB  - 175.
AU  - Dixon-Woods, M
AU  - Shaw, R
AU  - Agarwal, S
AU  - Smith, J
TI  - The problem of appraising qualitative research
J2  - Qual Saf Health Care
PY  - 2004
VL  - 13
SP  - 223
EP  - 225
ER  - 
TY  - JOUR
LB  - 176.
AU  - Dixon-Woods, M
TI  - Appraising qualitative research for inclusion in systematic reviews: a quantitative and qualitative comparison of three methods
J2  - J Health Services Res Policy
PY  - 2007
VL  - 12
SP  - 42
EP  - 47
ER  - 
TY  - GEN
LB  - 177.
AU  - Centre for Reviews and Dissemination
TI  - Systematic reviews: CRD’s guidance for undertaking reviews in health care
CY  - York
PB  - NHS Centre for Reviews and Dissemination
PY  - 2009
ER  - 
TY  - CHAP
LB  - 178.
AU  - Ritchie, J
AU  - Spencer, L
TI  - Qualitative data analysis for applied policy research
A2  - Bryman, A
A2  - Burgess, RG
T2  - Analysing qualitative data
CY  - London
PB  - Routledge
PY  - 1994
ER  - 
TY  - BOOK
LB  - 179.
AU  - Barnett-Page, E
AU  - Thomas, J
TI  - Methods for the synthesis of qualitative research: a critical review. (01/09)
PB  - ESRC National Centre for Research Methods Working Paper Series
PY  - 2009
ER  - 
TY  - JOUR
LB  - 180.
AU  - Oliver, S
AU  - Rees, R
AU  - Clarke-Jones, L
AU  - Milne, R
AU  - Oakley, A
AU  - Gabbay, J
TI  - A multidimensional conceptual framework for analysing public involvement in health services research
J2  - Health Expect
PY  - 2008
VL  - 11
SP  - 72
EP  - 84
ER  - 
TY  - BOOK
LB  - 181.
AU  - Brunton, G
AU  - Oliver, S
AU  - Oliver, K
AU  - Lorenc, T
TI  - A synthesis of research addressing children’s, young people’s and parents’ views of walking and cycling for transport
CY  - London
PB  - EPPI-Centre, Social Science Research Unit, Institute of Education, University of London
PY  - 2006
ER  - 
TY  - BOOK
LB  - 182.
AU  - Huffman, S
TI  - Can marketing of multiple vitamin/mineral supplements reach the poor? The Vitaldía
CY  - Project, Bolivia
PY  - 2002
ER  - 
TY  - JOUR
LB  - 183.
AU  - Dixon-Woods, M
AU  - Bonas, S
AU  - Booth, A
AU  - Jones, DR
AU  - Miller, T
AU  - Sutton, AJ
TI  - How can systematic reviews incorporate qualitative research? A critical perspective
J2  - Qual Res
PY  - 2006
VL  - 6
SP  - 27
EP  - 44
ER  - 
TY  - BOOK
LB  - 184.
AU  - Miles, M
AU  - Huberman, A
TI  - Qualitative data analysis: a sourcebook of new methods
CY  - Newbury Park, CA
PB  - Sage
PY  - 1984
ER  - 
TY  - JOUR
LB  - 185.
AU  - Lindsey, LL
AU  - Hamner, HC
AU  - Prue, CE
AU  - Flores, AL
AU  - Valencia, D
AU  - Correa-Sierra, E
TI  - Understanding optimal nutrition among women of childbearing age in the United States and Puerto Rico: employing formative research to lay the foundation for national birth defects prevention campaigns
J2  - J Health Commun
PY  - 2007
VL  - 12
SP  - 733
EP  - 757
ER  - 
TY  - JOUR
LB  - 186.
AU  - Reedy, J
AU  - Haines, PS
AU  - Steckler, A
AU  - Campbell, MK
TI  - Qualitative comparison of dietary choices and dietary supplement use among older adults with and without a history of colorectal cancer
J2  - J Nutr Educ Behav
PY  - 2005
VL  - 37
SP  - 252
EP  - 258
ER  - 
TY  - JOUR
LB  - 187.
AU  - Legare, F
AU  - Stacey, D
AU  - Dodin, S
AU  - O’Connor, A
AU  - Richer, M
AU  - Griffiths, F
TI  - Women’s decision making about the use of natural health products at menopause: a needs assessment and patient decision aid
J2  - J Altern Complement Med
PY  - 2007
VL  - 13
SP  - 741
EP  - 749
ER  - 
TY  - JOUR
LB  - 188.
AU  - Spanner, ED
AU  - Duncan, AM
TI  - Prevalence of dietary supplement use in adult with chronic renal insufficiency
J2  - J Renal Nutr
PY  - 2005
VL  - 15
SP  - 204
EP  - 210
ER  - 
TY  - JOUR
LB  - 189.
AU  - Arcury, TA
AU  - Bell, RA
AU  - Vitolins, MZ
AU  - Quandt, SA
TI  - Rural older adults’ beliefs and behavior related to complementary and alternative medicine use
J2  - Complement Health Pract Rev
PY  - 2005
VL  - 10
SP  - 33
EP  - 44
ER  - 
TY  - JOUR
LB  - 190.
AU  - Connor, LH
TI  - Relief, risk and renewal: mixed therapy regimens in an Australian suburb
J2  - Social Sci Med
PY  - 2004
VL  - 59
SP  - 1695
EP  - 1705
ER  - 
TY  - JOUR
LB  - 191.
AU  - Huber, R
AU  - Koch, D
AU  - Beiser, I
AU  - Zschocke, I
AU  - Luedtke, R
TI  - Experience and attitudes towards CAM – a survey of internal and psychosomatic patients in a German university hospital
J2  - Altern Ther Health Med
PY  - 2004
VL  - 10
SP  - 32
EP  - 36
ER  - 
TY  - JOUR
LB  - 192.
AU  - Chagan, L
AU  - Bernstein, D
AU  - Cheng, JW
AU  - Kirschenbaum, HL
AU  - Rozenfeld, V
AU  - Caliendo, GC
TI  - Use of biological based therapy in patients with cardiovascular diseases in a university-hospital in New York City
J2  - BMC Complement Altern Med
PY  - 2005
VL  - 5
SP  - 4
ER  - 
TY  - JOUR
LB  - 193.
AU  - George, J
AU  - Ioannides-Demos, LL
AU  - Santamaria, NM
AU  - Kong, D
AU  - Stewart, K
TI  - Use of complementary and alternative medicines by patients with chronic obstructive pulmonary disease
J2  - Med J Aust
PY  - 2004
VL  - 181
SP  - 248
EP  - 251
ER  - 
TY  - JOUR
LB  - 194.
AU  - Fraenkel, L
AU  - Bogardus, ST, Jr
AU  - Concato, J
AU  - Wittink, DR
TI  - Treatment options in knee osteoarthritis: the patient’s perspective
J2  - Arch Intern Med
PY  - 2004
VL  - 164
SP  - 1299
EP  - 1304
ER  - 
TY  - JOUR
LB  - 195.
AU  - Miller, CK
AU  - Russell, T
AU  - Kissling, G
TI  - Decision-making patterns for dietary supplement purchases among women aged 25 to 45 years
J2  - J Am Dietet Assoc
PY  - 2003
VL  - 103
SP  - 1523
EP  - 1526
ER  - 
TY  - JOUR
LB  - 196.
AU  - Oldham, L
AU  - Kendall, P
AU  - Cobb, B
AU  - Banning, J
AU  - Slater, M
TI  - Perceptions of dietary supplements among older women with diabetes
J2  - The Diabetes Educator
PY  - 2004
VL  - 30
SP  - 658
EP  - 664
ER  - 
TY  - JOUR
LB  - 197.
AU  - Porter, M
AU  - Kolva, E
AU  - Ahl, R
AU  - Diefenbach, MA
TI  - Changing patterns of CAM use among prostate cancer patients two years after diagnosis: reasons for maintenance or discontinuation
J2  - Complement Ther Med
PY  - 2008
VL  - 16
SP  - 318
EP  - 324
ER  - 
TY  - JOUR
LB  - 198.
AU  - Cowan, R
AU  - Meiser, B
AU  - Giles, GG
AU  - Lindeman, GJ
AU  - Gaff, CL
TI  - The beliefs, and reported and intended behaviors of unaffected men in response to their family history of prostate cancer
J2  - Genet Med
PY  - 2008
VL  - 10
SP  - 430
EP  - 438
ER  - 
TY  - JOUR
LB  - 199.
AU  - Matthews, AK
AU  - Sellergren, SA
AU  - Huo, D
AU  - List, M
AU  - Fleming, G
TI  - Complementary and alternative medicine use among breast cancer survivors
J2  - J Altern Complement Med
PY  - 2007
VL  - 13
SP  - 555
EP  - 562
ER  - 
TY  - JOUR
LB  - 200.
AU  - Papaioannou, D
AU  - Carroll, C
AU  - Booth, A
AU  - Sutton, A
AU  - Wong, R
TI  - Literature searching for social science systematic reviews: consideration of a range of search techniques
J2  - Health Information and Libraries Journal
PY  - 2010
ER  - 
TY  - BOOK
LB  - 201.
AU  - Grayson, L
AU  - Gomersall, A
TI  - A difficult business: finding the evidence for social science reviews
PY  - 2003
CY  - London
PB  - ESRC UK Centre for Evidence Based Policy and Practice
ER  - 
TY  - JOUR
LB  - 202.
AU  - Prochaska, J
AU  - Velicer, W
TI  - The transtheoretical model of health behavior change
J2  - Am J Health Prom
PY  - 1997
VL  - 12
SP  - 38
EP  - 48
ER  - 
TY  - JOUR
LB  - 203.
AU  - Demark-Wahnefried, W
AU  - Peterson, B
AU  - McBride, C
AU  - Lipkus, I
AU  - Clipp, E
TI  - Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas
J2  - Cancer
PY  - 2000
VL  - 88
SP  - 674
EP  - 684
ER  - 
TY  - CHAP
LB  - 204.
AU  - Strecher, VJ
AU  - Rosenstock, IM
TI  - The health belief model
A2  - Rimer, BK
T2  - Health Behavior and Health Education
CY  - San Francisco, CA
PB  - Jossey-Bass
PY  - 1997
SP  - 41
EP  - 59
ER  - 
TY  - JOUR
LB  - 205.
AU  - Floyd, DL
AU  - Prentice-Dunn, S
AU  - Rogers, RW
TI  - A meta-analysis of research on protection motivation theory
J2  - J Appl Soc Psychol
PY  - 2000
VL  - 30
SP  - 407
EP  - 429
ER  - 
TY  - JOUR
LB  - 206.
AU  - Milne, S
AU  - Sheeran, P
AU  - Orbell, S
TI  - Prediction and intervention in health-related behavior: a meta-analytic review of protection motivation theory
J2  - J Appl Soc Psychol
PY  - 2000
VL  - 30
SP  - 106
EP  - 143
ER  - 
TY  - JOUR
LB  - 207.
AU  - Horne, R
AU  - Weinman, J
TI  - Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication
J2  - Psychol Health
PY  - 2002
VL  - 17
SP  - 17
EP  - 32
ER  - 
TY  - JOUR
LB  - 208.
AU  - Fraenkel, L
AU  - Wittink, DR
AU  - Concato, J
AU  - Fried, T
TI  - Informed choice and the widespread use of anti-inflammatory drugs
J2  - Arthritis Rheum
PY  - 2004
VL  - 51
SP  - 210
EP  - 214
ER  - 
TY  - JOUR
LB  - 209.
AU  - Herve, C
AU  - Mullet, E
AU  - Sorum, PC
TI  - Age and medication acceptance
J2  - Exp Aging Res
PY  - 2004
VL  - 30
SP  - 253
EP  - 273
ER  - 
TY  - JOUR
LB  - 210.
AU  - Nahleh, Z
AU  - Tabbara, I
TI  - Complementary and alternative medicine in breast cancer patients
J2  - Pall Support Care
PY  - 2003
VL  - 1
SP  - 267
EP  - 273
ER  - 
TY  - JOUR
LB  - 211.
AU  - Verhoef, MJ
AU  - Balneaves, LG
AU  - Boon, HS
AU  - Vroegindewey, A
TI  - Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review
J2  - Integr Cancer Ther
PY  - 2005
VL  - 4
SP  - 274
EP  - 286
ER  - 
TY  - JOUR
LB  - 212.
AU  - Neuhouser, ML
AU  - Patterson, RE
AU  - Levy, L
TI  - Motivations for using vitamin and mineral supplements
J2  - J Am Dietet Assoc
PY  - 1999
VL  - 99
SP  - 851
EP  - 854
ER  - 
TY  - JOUR
LB  - 213.
AU  - Velicer, CMU
TI  - Vitamin and mineral supplement use among US adults after cancer diagnosis: A systematic review
J2  - J Clin Oncol
PY  - 2008
VL  - 26
SP  - 665
EP  - 673
ER  - 
TY  - JOUR
LB  - 214.
AU  - Emmons, KM
AU  - McBride, CM
AU  - Puleo, E
AU  - Pollak, KI
AU  - Clipp, E
AU  - Kuntz, K
TI  - Project PREVENT: a randomized trial to reduce multiple behavioral risk factors for colon cancer
J2  - Cancer Epidemiol Biomarkers Prev
PY  - 2005
VL  - 14
SP  - 1453
EP  - 1459
ER  - 
TY  - JOUR
LB  - 215.
AU  - Ladabaum, U
TI  - Potential cost-effectiveness of colorectal cancer chemoprevention with nonsteroidal anti-inflammatory drugs
J2  - Expert Rev Pharmacoecon Outcomes Res
PY  - 2003
VL  - 3
SP  - 757
EP  - 771
ER  - 
TY  - JOUR
LB  - 216.
AU  - Ladabaum, U
AU  - Chopra, CL
AU  - Huang, G
AU  - Scheiman, JM
AU  - Chernew, ME
AU  - Fendrick, AM
TI  - Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer: a cost-effectiveness analysis
J2  - Ann Intern Med
PY  - 2001
VL  - 135
SP  - 769
EP  - 781
ER  - 
TY  - JOUR
LB  - 217.
AU  - Ladabaum, U
AU  - Scheiman, JA
AU  - Fendrick, AM
TI  - Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis
J2  - Am J Med
PY  - 2003
VL  - 114
SP  - 546
EP  - 554
ER  - 
TY  - JOUR
LB  - 218.
AU  - Arguedas, MR
AU  - Heudebert, GR
AU  - Wilcox, CM
TI  - Surveillance colonoscopy or chemoprevention with COX-2 inhibitors in average-risk post-polypectomy patients: a decision analysis
J2  - Aliment Pharmacol Therapeut
PY  - 2001
VL  - 15
SP  - 631
EP  - 638
ER  - 
TY  - JOUR
LB  - 219.
AU  - Suleiman, S
AU  - Rex, DK
AU  - Sonnenberg, A
TI  - Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis
J2  - Gastroenterology
PY  - 2002
VL  - 122
SP  - 78
EP  - 84
ER  - 
TY  - JOUR
LB  - 220.
AU  - Dupont, AW
AU  - Arguedas, MR
AU  - Wilcox, CM
TI  - Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis
J2  - Aliment Pharmacol Therapeut
PY  - 2007
VL  - 26
SP  - 431
EP  - 441
ER  - 
TY  - JOUR
LB  - 221.
AU  - Hur, C
AU  - Simon, LS
AU  - Gazelle, GS
TI  - The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals
J2  - Cancer
PY  - 2004
VL  - 101
SP  - 189
EP  - 197
ER  - 
TY  - BOOK
LB  - 222.
AU  - Ries, L
AU  - Kosary, C
AU  - Hankey, B
AU  - Miller, B
AU  - Arras, A
TI  - SEER Cancer Statistics Review, 1973–1994
PY  - 1997
CY  - Bethesda, MD
PB  - National Cancer Institute
ER  - 
TY  - JOUR
LB  - 223.
TI  - Screening for colorectal cancer – United States, 1997
J2  - MMWR Morb Mortal Wkly Rep
PY  - 1999
VL  - 48
SP  - 116
EP  - 121
ER  - 
TY  - JOUR
LB  - 224.
AU  - Wagner, JL
AU  - Herdman, RC
AU  - Wadhwa, S
TI  - Cost effectiveness of colorectal cancer screening in the elderly
J2  - Ann Intern Med
PY  - 1991
VL  - 115
SP  - 807
EP  - 817
ER  - 
TY  - GEN
LB  - 225.
AU  - The DRG Handbook
TI  - Comparative Clinical and Finalncial Standards
CY  - Baltimore, MD
PB  - HCIA
PY  - 1997
ER  - 
TY  - JOUR
LB  - 226.
AU  - Winawer, SJ
AU  - Zauber, AG
AU  - O’Brien, MJ
AU  - Ho, MN
AU  - Gottlieb, L
AU  - Sternberg, SS
TI  - Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup
J2  - N Engl J Med
PY  - 1993
VL  - 328
SP  - 901
EP  - 906
ER  - 
TY  - JOUR
LB  - 227.
AU  - Silverstein, FE
AU  - Faich, G
AU  - Goldstein, JL
AU  - Simon, LS
AU  - Pincus, T
AU  - Whelton, A
TI  - Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study
J2  - J Am Med Assoc
PY  - 2000
VL  - 284
SP  - 1247
EP  - 1255
ER  - 
TY  - GEN
LB  - 228.
AU  - Medical Economics
TI  - Drug Topics Red Book
CY  - Montvale, NJ
PB  - Medical Economics Company
PY  - 2000
ER  - 
TY  - JOUR
LB  - 229.
AU  - Brown, ML
AU  - Riley, GF
AU  - Potosky, AL
AU  - Etzioni, RD
TI  - Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer
J2  - Med Care
PY  - 1999
VL  - 37
SP  - 1249
EP  - 1259
ER  - 
TY  - JOUR
LB  - 230.
AU  - Sonnenberg, A
AU  - Delco, F
AU  - Inadomi, JM
TI  - The cost-effectiveness of colonoscopy in screening for colorectal cancer
J2  - Ann Intern Med
PY  - 2000
VL  - 133
SP  - 573
EP  - 584
ER  - 
TY  - JOUR
LB  - 231.
AU  - Lee, J
AU  - Vigil, H
AU  - Leung, J
TI  - The hospital costs for diagnosis and treatment of colorectal cancer
J2  - Gastrointest Endosc
PY  - 1999
VL  - 49
SP  - AB145
ER  - 
TY  - JOUR
LB  - 232.
AU  - Janne, PA
AU  - Mayer, RJ
TI  - Chemoprevention of colorectal cancer
J2  - N Engl J Med
PY  - 2000
VL  - 342
SP  - 1960
EP  - 1968
ER  - 
TY  - JOUR
LB  - 233.
AU  - Fryback, DG
AU  - Dasbach, EJ
AU  - Klein, R
AU  - Klein, BE
AU  - Dorn, N
AU  - Peterson, K
TI  - The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors
J2  - Med Decis Making
PY  - 1993
VL  - 13
SP  - 89
EP  - 102
ER  - 
TY  - JOUR
LB  - 234.
AU  - Sanmuganathan, PS
AU  - Ghahramani, P
AU  - Jackson, PR
AU  - Wallis, EJ
AU  - Ramsay, LE
TI  - Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials
J2  - Heart
PY  - 2001
VL  - 85
SP  - 265
EP  - 271
ER  - 
TY  - JOUR
LB  - 235.
AU  - Steering Committee of the Physicians’ Health Study Research Group
TI  - Final report on the aspirin component of the ongoing Physicians’ Health Study
J2  - N Engl J Med
PY  - 1989
VL  - 321
SP  - 129
EP  - 135
ER  - 
TY  - JOUR
LB  - 236.
AU  - Spiegel, BM
AU  - Targownik, L
AU  - Dulai, GS
AU  - Gralnek, IM
TI  - The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis
J2  - Ann Intern Med
PY  - 2003
VL  - 138
SP  - 795
EP  - 806
ER  - 
TY  - JOUR
LB  - 237.
AU  - Bensen, S
AU  - Mott, LA
AU  - Dain, B
AU  - Rothstein, R
AU  - Baron, J
TI  - The colonoscopic miss rate and true one-year recurrence of colorectal neoplastic polyps. Polyp Prevention Study Group
J2  - Am J Gastroenterol
PY  - 1999
VL  - 94
SP  - 194
EP  - 199
ER  - 
TY  - JOUR
LB  - 238.
AU  - Tappenden, P
AU  - Chilcott, J
AU  - Eggington, S
AU  - Sakai, H
AU  - Karnon, J
AU  - Patnick, J
TI  - Option appraisal of population-based colorectal cancer screening programmes in England
J2  - Gut
PY  - 2007
VL  - 56
SP  - 677
EP  - 684
ER  - 
TY  - JOUR
LB  - 239.
AU  - Turnbull, RB
AU  - Kyle, K
AU  - Watson, FR
TI  - Cancer of the colon: the influence of the no touch isolation technique on survival rates
J2  - Ann Surg
PY  - 1967
VL  - 166
SP  - 420
EP  - 427
ER  - 
TY  - JOUR
LB  - 240.
AU  - Dukes, CE
TI  - The classification of cancer of the rectum
J2  - J Pathol Bacteriol
PY  - 1932
VL  - 35
SP  - 332
ER  - 
TY  - JOUR
LB  - 241.
AU  - Winawer, SJ
AU  - Zauber, AG
AU  - O’Brien, MJ
TI  - Randomised comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps
J2  - N Engl J Med
PY  - 1993
VL  - 328
SP  - 901
EP  - 906
ER  - 
TY  - GEN
LB  - 242.
AU  - Government Actuary’s Department
TI  - Interim Life Tables 2005–07
CY  - London
PB  - GAD
PY  - 2008
ER  - 
TY  - GEN
LB  - 243.
AU  - UKACR
TI  - Cancer Registry population denominators. 2009
IS  - Experimental Statistics provided by Office for National Statistics Crown Copyright
PY  - 2007
ER  - 
TY  - JOUR
LB  - 244.
AU  - Pendergrass, CJ
AU  - Edelstein, DL
AU  - Hylind, LM
AU  - Phillips, BT
AU  - Iacobuzio-Donohue, C
AU  - Romans, K
TI  - Occurrence of colorectal adenomas in younger adults: an epidemiologic necroscopy study
J2  - Clin Gastroenterol
PY  - 2008
VL  - 6
SP  - 1011
EP  - 1015
ER  - 
TY  - JOUR
LB  - 245.
AU  - Imperiale, TF
AU  - Wagner, DR
AU  - Lin, CY
AU  - Larkin, MD
AU  - Rogge, JD
AU  - Ransohoff, DF
TI  - Results of screening colonoscopy among persons 40 to 49 years of age
J2  - N Engl J Med
PY  - 2002
VL  - 346
SP  - 1781
ER  - 
TY  - JOUR
LB  - 246.
AU  - Bolland, M
TI  - Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial
J2  - BMJ
Y2  - 15Jan2008
ER  - 
TY  - GEN
LB  - 247.
AU  - National Collaborating Centre for Chronic Conditions
TI  - Osteoarthritis: National clinical guideline for care and management in adults
CY  - London
PB  - Royal College of Physicians
PY  - 2008
ER  - 
TY  - ELEC
LB  - 248.
AU  - British Heart Foundation
TI  - Incidence of myocardial infarction
PY  - 2009
UR  - www.heartstats.org/
ER  - 
TY  - JOUR
LB  - 249.
AU  - Tappenden, P
AU  - Jones, R
AU  - Paisley, S
AU  - Carroll, C
TI  - Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer
J2  - Health Technol Assess
PY  - 2007
VL  - 11
IS  - 12
ER  - 
TY  - JOUR
LB  - 250.
AU  - Ko, CY
AU  - Maggard, M
AU  - Livingston, EH
TI  - Evaluating health utility in patients with melanoma, breast cancer, colon cancer and lung cancer: A nationwide population-based assessment
J2  - J Surg Res
PY  - 2003
VL  - 114
SP  - 1
EP  - 5
ER  - 
TY  - JOUR
LB  - 251.
AU  - Ness, RM
AU  - Holmes, AM
AU  - Klein, R
AU  - Dittus, R
TI  - Utility valuations for outcome states of colorectal cancer
J2  - J Gastroenterol
PY  - 1999
VL  - 94
SP  - 1650
EP  - 1657
ER  - 
TY  - JOUR
LB  - 252.
AU  - Ramsey, SD
AU  - Andersen, MR
AU  - Etzioni, R
AU  - Moinpour, CM
AU  - Peacock, S
AU  - Potosky, A
TI  - Quality of life in survivors of colorectal cancer
J2  - Cancer
PY  - 2000
VL  - 88
SP  - 1294
EP  - 1303
ER  - 
TY  - JOUR
LB  - 253.
AU  - Petrou, S
AU  - Campbell, N
TI  - Stabilisation in colorectal cancer
J2  - Int J Pall Nurs
PY  - 1997
VL  - 3
SP  - 275
EP  - 280
ER  - 
TY  - JOUR
LB  - 254.
AU  - Maughan, MT
AU  - Ledermann, TS
AU  - Topham, JA
AU  - James, C
AU  - Gwyther, R
AU  - Smith, SJ
TI  - Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
J2  - Lancet
PY  - 2007
VL  - 370
SP  - 143
EP  - 152
ER  - 
TY  - BOOK
LB  - 255.
AU  - Corrie, P
TI  - The MABEL study. An open, uncontrolled, multicentre, phase II study of Erbitux. (cetuximab) in combination with irinotecan in pateints with metastatic colorectal carcinoma expressing the epidermal grwoth factor receptor and having progressed on a defined irinotecan-based regimen as most recent treatment
PY  - 2005
PB  - National Research Register
ER  - 
TY  - GEN
LB  - 256.
AU  - NICE
TI  - Guide to the methods of technology apprasial
CY  - London
PB  - NICE
PY  - 2008
ER  - 
TY  - GEN
LB  - 257.
AU  - Department of Health
TI  - Health Survey for England, 1996
CY  - London
PB  - DoH
PY  - 1998
ER  - 
TY  - JOUR
LB  - 258.
AU  - Ness, RM
AU  - Holmes, AM
AU  - Klein, R
AU  - Dittus, R
TI  - Utility valuations for outcome states of colorectal cancer
J2  - Am J Gastroenterol
PY  - 1999
VL  - 94
SP  - 1650
EP  - 1657
ER  - 
TY  - JOUR
LB  - 259.
AU  - Pilgrim, H
AU  - Tappenden, P
AU  - Chilcott, J
AU  - Bending, M
AU  - Trueman, P
AU  - Shorthouse, A
TI  - The costs and benefits of bowel cancer service developments using discrete event simulation
J2  - J Operat Res Soc
Y2  - 22Oct2008
ER  - 
TY  - BOOK
LB  - 260.
AU  - Curtis, L
TI  - Unit Costs of Health and Social Care 2008
CY  - Canterbury
PB  - PSSRU
PY  - 2008
ER  - 
TY  - GEN
LB  - 261.
AU  - Department of Health
TI  - NHS Reference Costs 2005
CY  - London
PB  - DoH
PY  - 2006
ER  - 
TY  - GEN
LB  - 262.
AU  - Department of Health
TI  - NHS Reference Costs 2006–07
CY  - London
PB  - DoH
PY  - 2008
ER  - 
TY  - JOUR
LB  - 263.
AU  - Burch, JA
AU  - Soares-Weiser, K
AU  - St John, DJ
AU  - Duffy, S
AU  - Smith, S
AU  - Kleijen, J
TI  - Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review
J2  - J Med Screen
PY  - 2007
VL  - 14
SP  - 132
EP  - 137
ER  - 
TY  - BOOK
LB  - 264.
AU  - Weller, D
AU  - Moss, S
AU  - Butler, P
AU  - Campbell, C
AU  - Coleman, D
AU  - Melia, J
TI  - English Pilot of Bowel Cancer Screening: an evaluation of the second round
PY  - 2006
PB  - Final Report to the Department of Health
ER  - 
TY  - JOUR
LB  - 265.
AU  - Van Rijn, JC
AU  - Reisma, JB
AU  - Stoker, J
TI  - Polyp miss rate determined by tandem colonoscopy: a systematic review
J2  - Am J Gastroenterol
PY  - 2006
VL  - 101
SP  - 343
EP  - 350
ER  - 
TY  - JOUR
LB  - 266.
AU  - Bressler, B
AU  - Paszat, L
AU  - Chen, D
AU  - Rothwell, D
AU  - Vinden, C
AU  - Rabeneck, L
TI  - Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis
J2  - Gastoenterology
PY  - 2007
VL  - 132
SP  - 96
EP  - 102
ER  - 
TY  - JOUR
LB  - 267.
AU  - Cuzick, J
AU  - Otto, F
AU  - Baron, J
AU  - Brown, P
AU  - Burn, B
AU  - Greenwald, P
TI  - Aspirin and non-steriodal anti-inflammatory drugs for cancer prevention: an international consensus statement
J2  - Lancet
PY  - 2009
VL  - 10
SP  - 501
EP  - 507
ER  - 
TY  - JOUR
LB  - 268.
AU  - Brennan, A
AU  - Kharroubi, S
AU  - O’Hagen, A
AU  - Chilcott, J
TI  - Calculating partial expected value of perfect information via Monte Carlo sampling algorithms
J2  - Med Decision Making
PY  - 2007
VL  - 27
SP  - 448
ER  - 
TY  - JOUR
LB  - 269.
AU  - Asano, TK
AU  - McLeod, RS
TI  - Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review
J2  - Dis Colon Rectum
PY  - 2004
VL  - 47
SP  - 665
EP  - 673
ER  - 
TY  - ELEC
LB  - 270.
AU  - Velicer, WF
AU  - Prochaska, JO
AU  - Fava, JL
AU  - Norman, GJ
AU  - Redding, CA
TI  - Transtheoretical model of change
PY  - 2009
UR  - http://www.uri.edu/research/cprc/TTM/detailedoverview.htm
ER  - 
TY  - BOOK
LB  - 271.
AU  - Moustakas, C
TI  - Phenomenological research methods
CY  - Thousand Oaks, CA
PB  - Sage
PY  - 1994
ER  -